Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine - Trial NCT06335160
Access comprehensive clinical trial information for NCT06335160 through Pure Global AI's free database. This phase not specified trial is sponsored by Tanta University and is currently Not yet recruiting. The study focuses on Ulcerative Colitis. Target enrollment is 46 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Tanta University
Timeline & Enrollment
N/A
Apr 01, 2024
May 01, 2025
Primary Outcome
change in disease activity,change in Partial Mayo Scoring Index (PMSI) assessment for Ulcerative Colitis Activity
Summary
To evaluate the possible efficacy and safety of mebendazole in patients with ulcerative
 colitis treated with mesalamine
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06335160
Non-Device Trial